The words “you have cancer” are life-changing for everyone impacted by a new diagnosis. AbbVie understands this, and that is why we have joined forces with leading global patient advocates to increase awareness about blood cancers.
Press Kit Items
Together with U.S. News and World Report we break down the basics of cancers that originate in the blood.
Jun 14, 2023
In the first episode of our ongoing “Blood Cancer, Explained” video series, we were joined by our partners from the Leukemia & Lymphoma Society (LLS) and Advanced Practitioner Society for Hematology and Oncology (APSHO) to discuss the complexities of blood cancer, information about treatment options, and explore how the blood cancer community can come together to continue to support patients to meet the needs of patients today and in the future.
Jun 14, 2023
In the second episode of our ongoing “Blood Cancer, Explained” video series, we were joined by advocacy partners from the CLL Society and Lymphoma Research Foundation (LRF) to discuss the emotional complexities patients and caregivers face after a blood cancer diagnosis, particularly chronic lymphocytic leukemia (CLL). As part of this conversation, findings from AbbVie’s U.S. Emotional Impact Report were discussed.
On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.
100+ unique blood cancers exist and most fall under three main types: leukemia, lymphoma and myeloma. Learn more
Sep 27, 2022
An estimated 1.2 million blood cancer cases occur annually worldwide.
Together with U.S. News and World Report we break down the basics of cancers that originate in the blood.
Jun 14, 2023
In the first episode of our ongoing “Blood Cancer, Explained” video series, we were joined by our partners from the Leukemia & Lymphoma Society (LLS) and Advanced Practitioner Society for Hematology and Oncology (APSHO) to discuss the complexities of blood cancer, information about treatment options, and explore how the blood cancer community can come together to continue to support patients to meet the needs of patients today and in the future.
Jun 14, 2023
In the second episode of our ongoing “Blood Cancer, Explained” video series, we were joined by advocacy partners from the CLL Society and Lymphoma Research Foundation (LRF) to discuss the emotional complexities patients and caregivers face after a blood cancer diagnosis, particularly chronic lymphocytic leukemia (CLL). As part of this conversation, findings from AbbVie’s U.S. Emotional Impact Report were discussed.
On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.
100+ unique blood cancers exist and most fall under three main types: leukemia, lymphoma and myeloma. Learn more
Sep 27, 2022
An estimated 1.2 million blood cancer cases occur annually worldwide.
